Netcare Doubles Down on Clinical AI and Digital Dividend as Patient Volumes Stall
Financial Performance: Operating Leverage at Work
Netcare delivered a robust set of interim results for the six months ended March 2026, with revenue growing 4.8% to ZAR 13.3 billion and EBITDA up 6.6% to ZAR 2.5 billion. The EBITDA margin expanded 30 basis points to 18.8%, driven by what CEO Richard Friedland calls the “digital dividend” — cumulative savings from the CareOn electronic medical record now exceed ZAR 705 million since 2022, surpassing the total implementation cost. Adjusted headline earnings per share rose 21.9% to ZAR 0.717, helped by an aggressive share buyback program that has repurchased 12.6% of shares outstanding since 2023. The company declared an interim dividend of ZAR 0.44 per share, up 22.2%.
CFO Keith Gibson highlighted operating leverage: “the business has converted a 4.8% growth in revenue into 6.6% EBITDA growth and 7.4% growth in operating profit, achieving 1.5x operating leverage.” — Keith Gibson, Chief Financial Officer · 2026-05-25 Net debt-to-EBITDA remained conservative at 1.2x, even after returning ZAR 948 million to shareholders in dividends and buybacks.
Digital Transformation: From EMR to Clinical AI
The centerpiece of Netcare’s strategy is its clinical AI push. The company has deployed a sepsis prediction model across all ICUs, and is rolling out the Corsano CardioWatch wearable across 6,000 general ward beds. Friedland emphasized: “we are now beginning to deploy clinical AI that will genuinely make a significant difference and will reinforce clinical trust.” — Richard Friedland, Chief Executive Officer · 2026-05-25 The company is also investing in Quro Medical, Africa’s first virtual hospital, which extends hospital-level care into patients’ homes. This aligns with the broader AI momentum seen across global equity markets, but Netcare is applying it to a sector where trust is fragile.
Additionally, the company’s Quro Medical investment is a strategic move into virtual care, with ~90% of South African medical schemes covering the hospital-at-home benefit. This leverages the company’s existing infrastructure while addressing capacity constraints.
Renewable Energy and ESG as a Cost Lever
Netcare’s environmental sustainability program is not just about compliance — it’s delivering hard savings. The company has reduced energy intensity by 39% per bed, and its renewable energy initiatives have achieved an IRR of 40%. With renewable energy expected to meet 60% of its needs by 2027, it is structurally lowering its cost base. This is particularly relevant given rising electricity prices from Eskom, a recurring theme for South African corporates.
Guidance and Risks
Despite the strong earnings growth, patient volumes remain under pressure. Total patient days grew only 0.7% in H1, with acute patient days up just 0.4%. Management revised full-year guidance for acute patient days to a range of 0.3% to 0.8% growth, citing medical schemes amending benefit structures. Melanie Da Costa, CEO-elect, noted: “We've been very purposeful in our wording. It's not broad-based, but with reference to the schemes that you referred to, which have been very well covered publicly.” — Melanie Da Costa, Unknown - likely senior management or executive · 2026-05-25 The pressure is concentrated in a few large schemes, but the company expects the impact to be contained within the current year.
The key takeaway is that Netcare is shifting its growth engine from volume to technology. As Friedland concluded:
The digital divide is widening, the digital dividend is growing and Netcare is on the right side of both.
In the context of its patient day weakness, the company is betting that its AI-driven cost savings and clinical differentiation will sustain margins and shareholder returns. The medical scheme environment remains the biggest risk, but the company’s focus on operational efficiency and capital returns provides a buffer.